159 related articles for article (PubMed ID: 38201211)
1. A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting.
Libbrecht S; Vankerckhoven A; de Wijs K; Baert T; Thirion G; Vandenbrande K; Van Gorp T; Timmerman D; Coosemans A; Lagae L
Cells; 2023 Dec; 13(1):. PubMed ID: 38201211
[TBL] [Abstract][Full Text] [Related]
2. Handheld Microflow Cytometer Based on a Motorized Smart Pipette, a Microfluidic Cell Concentrator, and a Miniaturized Fluorescence Microscope.
Kim B; Kang D; Choi S
Sensors (Basel); 2019 Jun; 19(12):. PubMed ID: 31248214
[TBL] [Abstract][Full Text] [Related]
3. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
Liao JB; Gwin WR; Urban RR; Hitchcock-Bernhardt KM; Coveler AL; Higgins DM; Childs JS; Shakalia HN; Swensen RE; Stanton SE; Tinker AV; Wahl TA; Ancheta RG; McGonigle KF; Dai JY; Disis ML; Goff BA
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531249
[TBL] [Abstract][Full Text] [Related]
5. Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.
Raamanathan A; Simmons GW; Christodoulides N; Floriano PN; Furmaga WB; Redding SW; Lu KH; Bast RC; McDevitt JT
Cancer Prev Res (Phila); 2012 May; 5(5):706-16. PubMed ID: 22490510
[TBL] [Abstract][Full Text] [Related]
6. A new tool for routine testing of cellular protein expression: integration of cell staining and analysis of protein expression on a microfluidic chip-based system.
Buhlmann C; Preckel T; Chan S; Luedke G; Valer M
J Biomol Tech; 2003 Jun; 14(2):119-27. PubMed ID: 14676310
[TBL] [Abstract][Full Text] [Related]
7. An integrated microfluidic platform for rapid tumor cell isolation, counting and molecular diagnosis.
Hung LY; Chuang YH; Kuo HT; Wang CH; Hsu KF; Chou CY; Lee GB
Biomed Microdevices; 2013 Apr; 15(2):339-52. PubMed ID: 23315192
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer.
Connor JP; Felder M; Hank J; Harter J; Gan J; Gillies SD; Sondel P
J Immunother; 2004; 27(3):211-9. PubMed ID: 15076138
[TBL] [Abstract][Full Text] [Related]
9. New Approaches for Immune Directed Treatment for Ovarian Cancer.
Hardwick N; Frankel PH; Cristea M
Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
[TBL] [Abstract][Full Text] [Related]
10. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.
Wang CH; Weng CH; Che YJ; Wang K; Lee GB
Theranostics; 2015; 5(4):431-42. PubMed ID: 25699101
[TBL] [Abstract][Full Text] [Related]
12. Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.
Coleman S; Clayton A; Mason MD; Jasani B; Adams M; Tabi Z
Cancer Res; 2005 Aug; 65(15):7000-6. PubMed ID: 16061686
[TBL] [Abstract][Full Text] [Related]
13. Microfluidics and materials for smart water monitoring: A review.
Saez J; Catalan-Carrio R; Owens RM; Basabe-Desmonts L; Benito-Lopez F
Anal Chim Acta; 2021 Nov; 1186():338392. PubMed ID: 34756264
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Clinical Value of Interleukin 6 and CD45
Wertel I; Suszczyk D; Pawłowska A; Bilska M; Chudzik A; Skiba W; Paduch R; Kotarski J
J Immunol Res; 2020; 2020():1715064. PubMed ID: 33062717
[TBL] [Abstract][Full Text] [Related]
15. Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA.
Yu ZT; Guan H; Cheung MK; McHugh WM; Cornell TT; Shanley TP; Kurabayashi K; Fu J
Sci Rep; 2015 Jun; 5():11339. PubMed ID: 26074253
[TBL] [Abstract][Full Text] [Related]
16. High-throughput microbead assay system with a portable, cost-effective Wi-Fi imaging module, and disposable multi-layered microfluidic cartridges for virus and microparticle detection, and tracking.
Castro JM; Sommerhage F; Khanna R; Childs A; DeRoo D; Rajaraman S
Biomed Microdevices; 2023 Jun; 25(3):21. PubMed ID: 37284878
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of apoptotic markers versus cell cycle phase in living human cancer cells by microfluidic cytometry.
Akagi J; Skommer J; Matuszek A; Takeda K; Fujimura Y; Khoshmanesh K; Kalantar-Zadeh K; Mitchell A; Errington R; Smith PJ; Darzynkiewicz Z; Wlodkowic D
Proc SPIE Int Soc Opt Eng; 2013 Mar; 8615():. PubMed ID: 24386542
[TBL] [Abstract][Full Text] [Related]
18. A microfluidic cytometer for white blood cell analysis.
Peng T; Su X; Cheng X; Wei Z; Su X; Li Q
Cytometry A; 2021 Nov; 99(11):1107-1113. PubMed ID: 34369647
[TBL] [Abstract][Full Text] [Related]
19. An integrated microfluidic system for rapid, automatic and high-throughput staining of clinical tissue samples for diagnosis of ovarian cancer.
Huang SP; Chuang YJ; Lee WB; Tsai YC; Lin CN; Hsu KF; Lee GB
Lab Chip; 2020 Mar; 20(6):1103-1109. PubMed ID: 32040102
[TBL] [Abstract][Full Text] [Related]
20. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
